Burkina Faso
A snapshot of PrEP scale-up, registration and resources for Burkina Faso.

-
0-200Estimated Cumulative Number of People Initiating PrEP
Aggregates numbers reported from demonstration projects, PEPFAR dashboard and program/country reports where available. This is presented as a range due to difficulty in tracking precise numbers and possible double reporting.
-
148PEPFAR PrEP Target in COP 2022
Targets are set by PEPFAR country teams on an annual basis. Targets do not indicate funding is available for PrEP.
Data Updated: April 11, 2022
Drug Registration Status
-
Gilead's Truvada (TDF/FTC) registrationApproved
-
Generic versions of TDF/FTC for preventionData not available
-
Viiv’s Apretude (CAB for PrEP) RegistrationNot approved
-
IPM’s Dapivirine Ring RegistrationNot approved
Types of Projects
- Demonstration projects, which road-test the use of new options in real-world settings—not in a trial site. They have a formal evaluation component that is designed to address specific elements of introduction such as infrastructure needs and ways individuals can integrate it into daily activities.
Research, Demonstration and Implementation Projects
Funding
- ANRS
- Expertise France
Resources for Burkina Faso
- A Framework for Scaling Up PrEP can help implementers, government and advocates begin planning for and implementing PrEP programs.
- Click here for the latest information from the Burkina Faso Ministry of Health.